Novavax incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per ...

BANGKOK—The Chinese Consulate in Myanmar’s second-largest city has been slightly damaged by an explosive device, but there were no casualties, the military, independent media and a city resident said ...

The Dow Jones Industrial Average fell 382.15 points, or 0.86%, to 43,910.98, the S&P 500 lost 17.36 points, or 0.29%, to ...

Revenue: US$84.5m (down 55% from 3Q 2023). Net loss: US$121.3m (loss narrowed by 7.2% from 3Q 2023). US$0.76 loss per share ...

TD Cowen analyst Brendan Smith maintained a Buy rating on Passage Bio (PASG – Research Report) today. The company’s shares opened ...

Mamtani covers the Healthcare sector, focusing on stocks such as Cytokinetics, Novavax, and Harrow Health. According to TipRanks, Mamtani has an average return of -10.8% and a 28.60% success rate on ...

Health-care companies slipped as vaccine makers remained under pressure. Shares of Novavax plunged by 8%, compounding losses in the wake of the vaccine developer's earnings report. Rival Moderna lost ...

The study was based on outcomes seen among essential workers with COVID-19 infection from June 2021 to September 2022.

A total of 438 confirmed and probable cases of meningococcal disease were reported in 2023, the most US cases reported since ...